Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other …